Pluri (PLUR) FCF Margin (2011 - 2025)

Pluri (PLUR) reported FCF Margin of 2854.55% for Q4 2025, down 29238.0% year-over-year from N/an in Q4 2024, and down 62.7% quarter-over-quarter from 1754.43% in Q3 2025.

Pluri (PLUR) FCF Margin (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 12 years of FCF Margin data on file, last reported at 2854.55% in Q4 2025.

  • FCF Margin for Q4 2025 came in at 2854.55%, down 29238.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1643.99% (up 95572.0% YoY), and the FY2025 annual result was 1484.21%, up 414279.0% from the prior year.
  • FCF Margin retreated to 2854.55% in Q4 2025 per PLUR's latest filing, from 1754.43% in the prior quarter.
  • Over five years, FCF Margin peaked at 1142.86% in Q1 2025 and troughed at 317400.0% in Q4 2022.
  • A 4-year average of 25084.38% and a median of 3590.48% in 2023 frame the typical range for FCF Margin.
  • On a YoY basis, FCF Margin climbed as much as 31380952 bps in 2023 and fell as far as 296344 bps in 2023.
  • A 4-year view of FCF Margin shows it stood at 317400.0% in 2022, then jumped by 99 bps to 3590.48% in 2023, then rose by 29 bps to 2562.16% in 2024, then slipped by 11 bps to 2854.55% in 2025.
  • Business Quant data shows PLUR's FCF Margin at 2854.55% in Q4 2025, 1754.43% in Q3 2025, and 1491.71% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 43.35%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 -2,854.55%

Historic Data

Download Data
DateValue
Dec 31, 2025 -2,854.55%
Sep 30, 2025 -1,754.43%
Jun 30, 2025 -1,491.71%
Mar 31, 2025 -1,142.86%
Dec 31, 2024 -2,562.16%
Sep 30, 2024 -1,310.43%
Jun 30, 2024 -4,503.13%
Mar 31, 2024 -6,043.66%
Dec 31, 2023 -3,590.48%
Sep 30, 2023 -11,037.04%
Jun 30, 2023 -2,697.30%
Mar 31, 2023 -7,005.75%
Dec 31, 2022 -317,400.00%
Sep 30, 2022 -8,829.89%
Mar 31, 2022 -4,042.31%
Dec 31, 2019 -27,421.74%
Dec 31, 2018 -16,902.00%
Sep 30, 2018 -212,875.00%
Dec 31, 2017 -9,392.00%
Dec 31, 2015 -179.03%